ES2096651T3 - Derivados de 1-piperidinil alcanoilarilsulfonamida. - Google Patents

Derivados de 1-piperidinil alcanoilarilsulfonamida.

Info

Publication number
ES2096651T3
ES2096651T3 ES91911167T ES91911167T ES2096651T3 ES 2096651 T3 ES2096651 T3 ES 2096651T3 ES 91911167 T ES91911167 T ES 91911167T ES 91911167 T ES91911167 T ES 91911167T ES 2096651 T3 ES2096651 T3 ES 2096651T3
Authority
ES
Spain
Prior art keywords
piperidinyl
alcanoylaryl
sulfonamide
derivatives
alkanoylarylsulfonamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91911167T
Other languages
English (en)
Inventor
Albert A Carr
Richard C Dage
Thaddeus R Nieduzak
John E Koerner
Tung Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2096651T3 publication Critical patent/ES2096651T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Abstract

ESTE INVENTO TIENE POR OBJETIVO UNA NUEVA CLASE DE 1 PIPERIDINIL ALCANOILARILSULFONAMIDAS Y SU USO COMO AGENTES ANTIARRITMICOS.
ES91911167T 1990-06-07 1991-05-15 Derivados de 1-piperidinil alcanoilarilsulfonamida. Expired - Lifetime ES2096651T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53478490A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
ES2096651T3 true ES2096651T3 (es) 1997-03-16

Family

ID=24131528

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91911167T Expired - Lifetime ES2096651T3 (es) 1990-06-07 1991-05-15 Derivados de 1-piperidinil alcanoilarilsulfonamida.

Country Status (14)

Country Link
EP (1) EP0532629B1 (es)
JP (1) JP3032294B2 (es)
KR (1) KR100200461B1 (es)
AT (1) ATE144899T1 (es)
AU (1) AU650031B2 (es)
CA (1) CA2084082C (es)
DE (1) DE69123052T2 (es)
DK (1) DK0532629T3 (es)
ES (1) ES2096651T3 (es)
FI (1) FI98456C (es)
GR (1) GR3022327T3 (es)
HU (1) HU214587B (es)
NO (1) NO179205C (es)
WO (1) WO1991018603A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000481A1 (en) * 1993-06-23 1995-01-05 Merrell Dow Pharmaceuticals Inc. Piperidin-1-yl-2,2-dialkylpropanonearylsulfonamide derivatives
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
TWI249526B (en) * 1998-03-13 2006-02-21 Aventis Pharma Inc Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
US6713627B2 (en) 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
HUP0204496A3 (en) 2000-01-20 2004-07-28 Eisai Co Ltd Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same
RU2333200C2 (ru) 2003-03-07 2008-09-10 Астеллас Фарма Инк. Азотсодержащие гетероциклические производные, содержащие 2,6-дизамещенный стирил
JP5400843B2 (ja) * 2011-09-06 2014-01-29 本田技研工業株式会社 車両構造

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
PH23283A (en) * 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
PH25458A (en) * 1987-08-24 1991-07-01 Eisai Co Ltd Piperidine derivatives, therapeutic, preventive agents
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5064838A (en) * 1988-01-21 1991-11-12 Merrell Dow Pharmaceuticals 1,4-disubstituted-piperidinyl compounds as pain relievers
NZ236501A (en) * 1989-12-21 1992-12-23 Merrell Dow Pharma Piperidine derivatives and antithrombotic compositions

Also Published As

Publication number Publication date
EP0532629B1 (en) 1996-11-06
JP3032294B2 (ja) 2000-04-10
NO179205B (no) 1996-05-20
DK0532629T3 (da) 1996-11-25
FI925518A (fi) 1992-12-04
HU9203856D0 (en) 1993-04-28
NO924694L (no) 1992-12-04
GR3022327T3 (en) 1997-04-30
ATE144899T1 (de) 1996-11-15
CA2084082A1 (en) 1991-12-08
FI925518A0 (fi) 1992-12-04
HU214587B (hu) 1998-04-28
JPH06501242A (ja) 1994-02-10
AU7992291A (en) 1991-12-31
HUT64517A (en) 1994-01-28
DE69123052D1 (de) 1996-12-12
DE69123052T2 (de) 1997-03-06
KR930700441A (ko) 1993-03-15
EP0532629A1 (en) 1993-03-24
AU650031B2 (en) 1994-06-09
EP0532629A4 (es) 1994-03-09
FI98456B (fi) 1997-03-14
FI98456C (fi) 1997-06-25
NO924694D0 (no) 1992-12-04
KR100200461B1 (ko) 1999-06-15
NO179205C (no) 1996-08-28
CA2084082C (en) 2002-03-19
WO1991018603A1 (en) 1991-12-12

Similar Documents

Publication Publication Date Title
ES2179822T3 (es) Nuevas 4-arilpiperazinas y 4-arilpiperidinas.
PT641343E (pt) Derivados de 4-mercaptoacetilamino-¬2|benzazapinona (3) e a sua utilizacao como inibidores de encefalinase
ES2078234T3 (es) 1,3-dioxolanos sustituidos en posiciones 2 y 4, sintesis y uso de los mismos.
SE9004060L (sv) Bensazepin- och bensotiazepin-derivat
ES2096651T3 (es) Derivados de 1-piperidinil alcanoilarilsulfonamida.
ATE137225T1 (de) Dihydrochinolin nmda antagonisten
FI930411A (fi) Bombesin antagonister
DE69115116D1 (de) Heterocyclische NMDA Antagonisten.
KR900015532U (ko) 일부인
ITMI912654A1 (it) Combinazione di estrusore-calandra
KR940026816U (ko) 비누의 편리한 사용구
LV10421A (lv) Jaunie tetrahidronaftalina atvasinajumi
LT2389B (lt) Prailginto veikimo tablciu gavimo budas
RO97339A2 (ro) Sursa trifazata de foarte joasa frecventa
KR920013544U (ko) 스위치의 고정장치

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 532629

Country of ref document: ES